Glenn A Oclassen - Net Worth and Insider Trading
Glenn A Oclassen Net Worth
The estimated net worth of Glenn A Oclassen is at least $71,407 dollars as of 2024-04-25. Glenn A Oclassen is the President and CEO of Paratek Pharmaceuticals Inc and owns about 32,021 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $71,407. Details can be seen in Glenn A Oclassen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Glenn A Oclassen has not made any transactions after 2011-09-19 and currently still holds the listed stock(s).
Transaction Summary of Glenn A Oclassen
Glenn A Oclassen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Glenn A Oclassen owns 2 companies in total, including Verrica Pharmaceuticals Inc (VRCA) , and Paratek Pharmaceuticals Inc (PRTK) .
Click here to see the complete history of Glenn A Oclassen’s form 4 insider trades.
Insider Ownership Summary of Glenn A Oclassen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2018-06-14 | director |
| PRTK | Paratek Pharmaceuticals Inc | 2011-09-19 | director & President and CEO |
Glenn A Oclassen Latest Holdings Summary
Glenn A Oclassen currently owns a total of 1 stock. Glenn A Oclassen owns 32,021 shares of Paratek Pharmaceuticals Inc (PRTK) as of September 19, 2011, with a value of $71,407.
Latest Holdings of Glenn A Oclassen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2011-09-19 | 32,021 | 2.23 | 71,407 |
Holding Weightings of Glenn A Oclassen
Glenn A Oclassen Form 4 Trading Tracker
According to the SEC Form 4 filings, Glenn A Oclassen has made a total of 0 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years. The most-recent trade in Paratek Pharmaceuticals Inc is the acquisition of 1,667 shares on September 19, 2011, which cost Glenn A Oclassen around $116,000.
Insider Trading History of Glenn A Oclassen
- 1
Glenn A Oclassen Trading Performance
GuruFocus tracks the stock performance after each of Glenn A Oclassen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenn A Oclassen is 44.39%. GuruFocus also compares Glenn A Oclassen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenn A Oclassen within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Glenn A Oclassen's insider trading performs compared to the benchmark.
Performance of Glenn A Oclassen
Average Return
23.15%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.4 | 44.39 | 81.14 | 23.15 | -22.33 | -17.37 |
| Relative Return to S&P 500(%) | 17.51 | 39.65 | 67.91 | 7.95 | -37.11 | -33.39 |
Glenn A Oclassen Ownership Network
Ownership Network List of Glenn A Oclassen
Ownership Network Relation of Glenn A Oclassen
Glenn A Oclassen Owned Company Details
What does Verrica Pharmaceuticals Inc do?
Who are the key executives at Verrica Pharmaceuticals Inc?
Glenn A Oclassen is the director of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Ted White , and Chief Commercial Officer Joe Bonaccorso .
Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary
Over the past 18 months, Glenn A Oclassen made no insider transaction in Verrica Pharmaceuticals Inc (VRCA). Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net purchase of 2,060,199 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 84,376 shares made by Ted White , and a net sale of 71,108 shares made by Joe Bonaccorso .
In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.
Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verrica Pharmaceuticals Inc Insider Transactions
Glenn A Oclassen Mailing Address
Above is the net worth, insider trading, and ownership report for Glenn A Oclassen. You might contact Glenn A Oclassen via mailing address: 3290 West Bayshore Rd, Palo Alto Ca 94303.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
